Dr. Umair Majeed, MBBS, MD
Claim this profileMayo Clinic Jacksonville
Studies Stomach Cancer
Studies Lung Cancer
5 reported clinical trials
8 drugs studied
Area of expertise
1Stomach Cancer
Stage IV
Stage III
KRAS positive
2Lung Cancer
Stage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials Umair Majeed, MBBS, MD is currently running
IMM-1-104
for Solid Cancers
This trial is testing a new drug called IMM-1-104 to see if it can help treat advanced cancers with specific genetic changes. The drug works by blocking signals that make cancer cells grow.
Recruiting1 award Phase 1 & 2
Radioembolization + Immunotherapy
for Bile Duct Cancer
This phase I trial tests the safety and side effects of yttrium-90 (Y90) radioembolization combined with immunotherapy drugs tremelimumab and durvalumab in treating patients with intrahepatic cholangiocarcinoma (cancer of the bile ducts in the liver) that has spread to nearby tissue or lymph nodes (locally advanced) and cannot be removed by surgery (unresectable) who are not candidates for curative therapy or that has spread from where it first started (primary side) to multiple other places in the body (oligo-metastatic). Cholangiocarcinoma is a rare but aggressive cancer with limited curative options outside of surgery. Immunotherapy has shown modest benefit in hepatobiliary (liver, bile ducts, and gallbladder) cancers including cholangiocarcinoma. Radioembolization is a type of radiation therapy used to treat liver cancer that is advanced or has come back where tiny beads that hold the radioactive substance (radioisotope) yttrium Y90 are injected into or near the hepatic artery (the main blood vessel that carries blood to the liver). The beads collect in the tumor and the Y90 gives off radiation. This destroys the blood vessels that the tumor needs to grow and kills the tumor cells. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as durvalumab and tremelimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving Y90 radioembolization in combination with tremelimumab and durvalumab immunotherapy may be safe and beneficial in treating patients with locally advanced, unresectable or oligo-metastatic intrahepatic cholangiocarcinoma who are not candidates for curative therapy.
Recruiting1 award Phase 120 criteria
More about Umair Majeed, MBBS, MD
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Umair Majeed, MBBS, MD has experience with
- Durvalumab
- Tremelimumab
- Yttrium-90 Microsphere Radioembolization
- ELI-002 7P
- TP-1454
- CTX-009
Breakdown of trials Umair Majeed, MBBS, MD has run
Stomach Cancer
Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Umair Majeed, MBBS, MD specialize in?
Umair Majeed, MBBS, MD focuses on Stomach Cancer and Lung Cancer. In particular, much of their work with Stomach Cancer has involved Stage IV patients, or patients who are Stage III.
Is Umair Majeed, MBBS, MD currently recruiting for clinical trials?
Yes, Umair Majeed, MBBS, MD is currently recruiting for 2 clinical trials in Jacksonville Florida. If you're interested in participating, you should apply.
Are there any treatments that Umair Majeed, MBBS, MD has studied deeply?
Yes, Umair Majeed, MBBS, MD has studied treatments such as Durvalumab, Tremelimumab, Yttrium-90 Microsphere Radioembolization.
What is the best way to schedule an appointment with Umair Majeed, MBBS, MD?
Apply for one of the trials that Umair Majeed, MBBS, MD is conducting.
What is the office address of Umair Majeed, MBBS, MD?
The office of Umair Majeed, MBBS, MD is located at: Mayo Clinic Jacksonville, Jacksonville, Florida 32224 United States. This is the address for their practice at the Mayo Clinic Jacksonville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.